Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Aptevo Therapeutics Inc.

NASDAQ: APVO · Life Sciences · 11 alerts · CIK 1671584

Share price
$0.5486Close, Nov 16
Market cap
$1.9M
Shares outstanding
3.46MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Aptevo Therapeutics Inc. filings on SEC EDGAR ↗

8:59 AM ET 8-K
Business Update

Aptevo Therapeutics Business Update

Aptevo Therapeutics announced operational progress in its next-generation trispecific cancer programs, specifically focusing on optimizing manufacturing scalability for its lead candidate, APVO451. The company expects to initiate Investigational New Drug (IND) enabling studies for APVO451 in the first half of 2027. This update signals the transition of the trispecific platform from molecular design toward clinical development readiness.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.